Neurocrine Biosciences, Inc., a biopharmaceutical company, has been awarded a multiple award Federal Supply Schedule (FSS) contract from the General Services Administration (GSA) for Pharmaceuticals and Drugs (FSS-61-IB). Under this contract, Neurocrine provides pharmaceutical products, primarily the drug VALBENAZINE, to various agencies within the Department of Veterans Affairs (VA), including the Veterans Health Administration (VHA).
Through a series of firm fixed price delivery orders against the FSS contract, Neurocrine supplies VALBENAZINE 40mg and 80mg oral capsules to support the VA-VHA's treatment programs for neurological movement disorders, such as tardive dyskinesia, at VA medical facilities and networks, predominantly within Veterans Integrated Service Network 12 in California. The contract does not utilize any set-aside designations. Neurocrine has also provided pharmaceuticals to other federal agencies, such as the Department of Justice Federal Bureau of Prisons, through this GSA Schedule vehicle.
Generated 2/21/25, 9:04 AM